本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AC Immune SA

3.21
+0.10003.22%
盤後3.20-0.0100-0.31%18:12 EDT
成交量:50.78萬
成交額:163.53萬
市值:3.27億
市盈率:-3.64
高:3.40
開:3.29
低:3.11
收:3.11
52周最高:4.00
52周最低:1.43
股本:1.02億
流通股本:4,094.76萬
量比:2.07
換手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-0.8828
每股收益(LYR):-0.8828
淨資產收益率:-89.65%
總資產收益率:-22.35%
市淨率:5.77
市盈率(LYR):-3.64

資料載入中...

2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/03/16

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/03/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]